Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
Abstract Ascorbic acid represents an appealing option for clinicians to utilize in the context of the global COVID-19 pandemic due to its proposed clinical efficacy, relative safety, and low cost. The aim of this study was to evaluate the efficacy and safety of using ascorbic acid in supplemental do...
Enregistré dans:
Auteurs principaux: | Khalid Al Sulaiman, Ohoud Aljuhani, Khalid Bin Saleh, Hisham A. Badreldin, Abdullah Al Harthi, Mohammed Alenazi, Aisha Alharbi, Rahmah Algarni, Shmeylan Al Harbi, Abdullah M. Alhammad, Ramesh Vishwakarma, Sarah Aldekhyl |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/01acb48b22bb49dda4056fb524eebae5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Author Correction: Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
par: Khalid Al Sulaiman, et autres
Publié: (2021) -
Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study
par: Ohoud Aljuhani, et autres
Publié: (2021) -
The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study
par: Khalid Al Sulaiman, et autres
Publié: (2021) -
Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study
par: Khalid Al Sulaiman, et autres
Publié: (2021) -
Major Cardiovascular Advances: Highlights from the 2019 American College of Cardiology Annual Scientific Session
par: Hisham A Badreldin, et autres
Publié: (2020)